Association Between Dose Dialysis by Kt and Mortality

N/ACompletedNCT01932853

NephroCare Spain6,129 enrolled

Overview

The aim of this study is to assess whether patients receiving current recommendations of an adequate dialysis dose by Kt adjusted for body surface area improved survival at 24 months compared to those who do not get it, as well as assess whether patients receiving a dose greater obtain more benefit.

Study Type

OBSERVATIONAL

Enrollment

6,129

Conditions

End Stage Renal Disease Hemodialysis Patients

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * \> 18 years old * \> six months on hemodialysis * Receiving 3 sessions of dialysis per week * Having 5 or more valid measures of Kt during the month Exclusion Criteria: * active chronic inflammatory diseases * Liver cirrhosis * Neoplasms * Chronic immunosuppression or use of anti-inflammatory

Locations (1)

NephroCare Spain

Madrid, Madrid, Spain

Outcomes

Primary Outcomes

Mortality

Time frame: two years

Secondary Outcomes

Hospitalization

Time frame: two years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.